These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2401790

  • 1. Comparative long-term effects in a mouse model system of influenza whole virus and purified neuraminidase vaccines followed by sequential infections.
    Johansson BE, Kilbourne ED.
    J Infect Dis; 1990 Oct; 162(4):800-9. PubMed ID: 2401790
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Contribution of Neuraminidase to the Efficacy of Seasonal Split Influenza Vaccines in the Ferret Model.
    Rosu ME, Kok A, Bestebroer TM, de Meulder D, Verveer EP, Pronk MR, Dekker LJM, Luider TM, Richard M, van den Brand JMA, Fouchier RAM, Herfst S.
    J Virol; 2022 Mar 23; 96(6):e0195921. PubMed ID: 35107371
    [Abstract] [Full Text] [Related]

  • 5. Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.
    Johansson BE, Matthews JT, Kilbourne ED.
    Vaccine; 1998 Mar 23; 16(9-10):1009-15. PubMed ID: 9682352
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP, Blanchfield K, Belser JA, Music N, Tzeng WP, Holiday C, Burroughs A, Sun X, Maines TR, Levine MZ, York IA.
    J Virol; 2017 Oct 15; 91(20):. PubMed ID: 28768855
    [Abstract] [Full Text] [Related]

  • 9. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
    Beljanski V, Chiang C, Kirchenbaum GA, Olagnier D, Bloom CE, Wong T, Haddad EK, Trautmann L, Ross TM, Hiscott J.
    J Virol; 2015 Oct 15; 89(20):10612-24. PubMed ID: 26269188
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Programmed antigenic stimulation: kinetics of the immune response to challenge infections of mice primed with influenza inactivated whole virus or neuraminidase vaccine.
    Johansson BE, Kilbourne ED.
    Vaccine; 1991 May 15; 9(5):330-3. PubMed ID: 1872017
    [Abstract] [Full Text] [Related]

  • 12. Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice.
    Johansson BE, Grajower B, Kilbourne ED.
    Vaccine; 1993 May 15; 11(10):1037-9. PubMed ID: 8212824
    [Abstract] [Full Text] [Related]

  • 13. Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model.
    Rota PA, De BK, Shaw MW, Black RA, Gamble WC, Kendal AP.
    Virus Res; 1990 Apr 15; 16(1):83-93. PubMed ID: 2349834
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL, Misplon JA, Lawson CM, Subbarao EK, Connors M, Murphy BR.
    J Immunol; 1993 Jun 15; 150(12):5484-93. PubMed ID: 8390536
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A, Oishi I, Minekawa Y, Kunita N, Funahashi S, Yagura H.
    Biken J; 1979 Sep 15; 22(3):91-8. PubMed ID: 533537
    [No Abstract] [Full Text] [Related]

  • 20. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.